Sonni, Ida
Sonni, Ida
Dipartimento di Medicina sperimentale e clinica
18F-FSPG PET/CT Imaging of System xC- Transporter Activity in Patients with Primary and Metastatic Brain Tumors
2022-01-01 Wardak, M; Sonni, I; Fan, A; Minamimoto, R; Jamali, M; Hatami, N; Zaharchuk, G; Fischbein, N; Nagpal, S; Li, Gordon; Koglin, N; Berndt, M; Bullich, S; Stephens, A; Dinkelborg, L; Abel, T; Manning, Hc; Rosenberg, J; Chin, F; Gambhir, S; Mittra E., joint co-first authorship
68Ga-FAPI-46 and 18F-FDG PET/CT in a patient with immune-related thyroiditis induced by immune checkpoint inhibitors.
2021-01-01 Hotta, M; Sonni, I; Benz, Mr; Gafita, A; Bahri, S; Shuch, Bm; Yu, R; Liu, St; Czernin, J; Calais, J
68Ga-FAPI-46 diffuse bilateral breast uptake in a patient with cervical cancer after hormonal stimulation
2020-01-01 Sonni, I; Lee-Felker, S; Memarzadeh, S; Quinn, Mm; Mone, Ce; Lükerath, K; Czernin, J; Calais, J
An 8-week open label trial of L-Threonic Acid Magnesium Salt in patients with mild to moderate dementia
2017-01-01 Wroolie, Te; Chen, K; Watson, Kt; Iagaru, A; Sonni, I; Snyder, N; Lee, W; Reiman, Em; Rasgon, Nl
Clinical validity of presynaptic dopaminergic imaging with 123I-ioflupane and noradrenergic imaging with 123I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development framework.
2017-01-01 Sonni, I; Ratib, O; Boccardi, M; Picco, A; Herholz, K; Nobili, F; Varrone, A.
Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts.
2021-01-01 Provost, K; Iaccarino, L; Soleimani-Meigooni, Dn; Baker, S; Edwards, L; Eichenlaub, U; Hansson, O; Jagust, W; Janabi, M; La Joie, R; Lesman-Segev, O; Mellinger, Tj; Miller, Bl; Ossenkoppele, R; Pham, J; Smith, R; Sonni, I; Strom, A; Mattsson-Carlgren, N; Rabinovici, Gd; Alzheimer’s Disease Neuroimaging Initiative, (ADNI).
Evaluation of a visual interpretation method for tau-PET with 18F-flortaucipir
2020-01-01 Sonni, I; Lesman Segev, Oh; Baker, Sl; Iaccarino, L; Korman, D; Rabinovici, Gd; Jagust, Wj; Landau, Sm; La Joie, R; Alzheimer's Disease Neuroimaging, Initiative
Functional imaging in neurodegenerative disorders: past, present and future
2014-01-01 Pagani, M; Sonni, I; Capriotti, G
Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
2022-01-01 Sonni, I; Felker, Er; Lenis, At; Sisk, Ae; Bahri, S; Allen-Auerbach, M; Armstrong, Wr; Suvannarerg, V; Tubtawee, T; Grogan, T; Elashoff, D; Czernin, J; Raman, Sr; Reiter, Re; Calais, J
Imaging of Prostate Cancer Using 68Ga-labeled Bombesin
2017-01-01 Sonni, I; Baratto, L; Iagaru, A
Imaging T-lymphocytes in inflammatory diseases: a nuclear medicine approach
2014-01-01 Malviya, G; Galli, F; Sonni, I; Signore, A.
Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single Center Study
2020-01-01 Sonni, I; Eiber, M; Fendler, Wp; Alano, Rm; Vangala, V; Kishan, Au; Nickols, N; Rettig, Mb; Reiter, R; Czernin, J; Calais, J
Initial Experience with a SiPM-based PET/CT Scanner: Influence of Acquisition Time on Image Quality
2018-01-01 Sonni, I; Baratto, L; Park, S; Hatami, N; Srinivas, S; Davidzon, G; Gambhir, Ss; Iagaru, A
Optimal acquisition time window and simplified quantification of dopamine transporter availability using 18F-FE-PE2I in healthy controls and Parkinson's disease patients.
2016-01-01 Sonni, I; Fazio, P; Schain, M; Halldin, C; Svenningsson, P; Farde, L; Varrone, A
PET Imaging of Glioblastoma
2018-01-01 Sonni, Ida; Nobashi, Tomomi; Iagaru, Andrei
PET imaging towards individualized management of urological and gynecological malignancies
2016-01-01 Sonni, I; Iagaru, A
PET/MRI in Brain Tumors
2018-01-01 Sonni, Ida; Garibotto, Valentina; Massoud., Devsmita Das and Tarik
PET/MRI in Prostate Cancer
2018-01-01 Sonni, I; Baratto, L; Freitag, Mt; Giesel, F; Eiber, M; Iagaru, A
Predictive factors for upstaging by prostate specific membrane antigen PET in high-risk prostate cancer: a post-hoc analysis
2021-01-01 Ma, Tm; Gafita, A; Shabsovich, D; Juarez, J; Thin, P; Armstrong, Wr; Sonni, I; Nguyen, K; Lok, V; Reiter, Re; Rettig, Mb; Steinberg, Ml; Yang, Dd; Muralidhar, V; Chu, C; Feng, F; Savjani, R; Deng, J; Parikh, Nr; Nickols, Ng; Czernin, J; Calais, J; Kishan, Au
Prospective Evaluation of 68Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Conventional Imaging
2018-01-01 Minamimoto, R; Sonni, I; Hancock, S; Vasanawala, S; Loening, A; Gambhir, Ss; Iagaru, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 18F-FSPG PET/CT Imaging of System xC- Transporter Activity in Patients with Primary and Metastatic Brain Tumors | 1-gen-2022 | Wardak, M; Sonni, I; Fan, A; Minamimoto, R; Jamali, M; Hatami, N; Zaharchuk, G; Fischbein, N; Nagpal, S; Li, Gordon; Koglin, N; Berndt, M; Bullich, S; Stephens, A; Dinkelborg, L; Abel, T; Manning, Hc; Rosenberg, J; Chin, F; Gambhir, S; Mittra E., joint co-first authorship | |
| 68Ga-FAPI-46 and 18F-FDG PET/CT in a patient with immune-related thyroiditis induced by immune checkpoint inhibitors. | 1-gen-2021 | Hotta, M; Sonni, I; Benz, Mr; Gafita, A; Bahri, S; Shuch, Bm; Yu, R; Liu, St; Czernin, J; Calais, J | |
| 68Ga-FAPI-46 diffuse bilateral breast uptake in a patient with cervical cancer after hormonal stimulation | 1-gen-2020 | Sonni, I; Lee-Felker, S; Memarzadeh, S; Quinn, Mm; Mone, Ce; Lükerath, K; Czernin, J; Calais, J | |
| An 8-week open label trial of L-Threonic Acid Magnesium Salt in patients with mild to moderate dementia | 1-gen-2017 | Wroolie, Te; Chen, K; Watson, Kt; Iagaru, A; Sonni, I; Snyder, N; Lee, W; Reiman, Em; Rasgon, Nl | |
| Clinical validity of presynaptic dopaminergic imaging with 123I-ioflupane and noradrenergic imaging with 123I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development framework. | 1-gen-2017 | Sonni, I; Ratib, O; Boccardi, M; Picco, A; Herholz, K; Nobili, F; Varrone, A. | |
| Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts. | 1-gen-2021 | Provost, K; Iaccarino, L; Soleimani-Meigooni, Dn; Baker, S; Edwards, L; Eichenlaub, U; Hansson, O; Jagust, W; Janabi, M; La Joie, R; Lesman-Segev, O; Mellinger, Tj; Miller, Bl; Ossenkoppele, R; Pham, J; Smith, R; Sonni, I; Strom, A; Mattsson-Carlgren, N; Rabinovici, Gd; Alzheimer’s Disease Neuroimaging Initiative, (ADNI). | |
| Evaluation of a visual interpretation method for tau-PET with 18F-flortaucipir | 1-gen-2020 | Sonni, I; Lesman Segev, Oh; Baker, Sl; Iaccarino, L; Korman, D; Rabinovici, Gd; Jagust, Wj; Landau, Sm; La Joie, R; Alzheimer's Disease Neuroimaging, Initiative | |
| Functional imaging in neurodegenerative disorders: past, present and future | 1-gen-2014 | Pagani, M; Sonni, I; Capriotti, G | |
| Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial | 1-gen-2022 | Sonni, I; Felker, Er; Lenis, At; Sisk, Ae; Bahri, S; Allen-Auerbach, M; Armstrong, Wr; Suvannarerg, V; Tubtawee, T; Grogan, T; Elashoff, D; Czernin, J; Raman, Sr; Reiter, Re; Calais, J | |
| Imaging of Prostate Cancer Using 68Ga-labeled Bombesin | 1-gen-2017 | Sonni, I; Baratto, L; Iagaru, A | |
| Imaging T-lymphocytes in inflammatory diseases: a nuclear medicine approach | 1-gen-2014 | Malviya, G; Galli, F; Sonni, I; Signore, A. | |
| Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single Center Study | 1-gen-2020 | Sonni, I; Eiber, M; Fendler, Wp; Alano, Rm; Vangala, V; Kishan, Au; Nickols, N; Rettig, Mb; Reiter, R; Czernin, J; Calais, J | |
| Initial Experience with a SiPM-based PET/CT Scanner: Influence of Acquisition Time on Image Quality | 1-gen-2018 | Sonni, I; Baratto, L; Park, S; Hatami, N; Srinivas, S; Davidzon, G; Gambhir, Ss; Iagaru, A | |
| Optimal acquisition time window and simplified quantification of dopamine transporter availability using 18F-FE-PE2I in healthy controls and Parkinson's disease patients. | 1-gen-2016 | Sonni, I; Fazio, P; Schain, M; Halldin, C; Svenningsson, P; Farde, L; Varrone, A | |
| PET Imaging of Glioblastoma | 1-gen-2018 | Sonni, Ida; Nobashi, Tomomi; Iagaru, Andrei | |
| PET imaging towards individualized management of urological and gynecological malignancies | 1-gen-2016 | Sonni, I; Iagaru, A | |
| PET/MRI in Brain Tumors | 1-gen-2018 | Sonni, Ida; Garibotto, Valentina; Massoud., Devsmita Das and Tarik | |
| PET/MRI in Prostate Cancer | 1-gen-2018 | Sonni, I; Baratto, L; Freitag, Mt; Giesel, F; Eiber, M; Iagaru, A | |
| Predictive factors for upstaging by prostate specific membrane antigen PET in high-risk prostate cancer: a post-hoc analysis | 1-gen-2021 | Ma, Tm; Gafita, A; Shabsovich, D; Juarez, J; Thin, P; Armstrong, Wr; Sonni, I; Nguyen, K; Lok, V; Reiter, Re; Rettig, Mb; Steinberg, Ml; Yang, Dd; Muralidhar, V; Chu, C; Feng, F; Savjani, R; Deng, J; Parikh, Nr; Nickols, Ng; Czernin, J; Calais, J; Kishan, Au | |
| Prospective Evaluation of 68Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Conventional Imaging | 1-gen-2018 | Minamimoto, R; Sonni, I; Hancock, S; Vasanawala, S; Loening, A; Gambhir, Ss; Iagaru, A |